BioELife Corp. (LITH)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | 800.00 | 800.00 |
| Gross Profit | - | - | - | - | -800.00 | -800.00 |
| Operating Expenses | - | - | - | - | 73.74 Thousand | 125.05 Thousand |
| Selling, General and Administrative Expenses | - | - | - | - | 73.74 Thousand | 80.81 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | - | - | - | - | 73.74 Thousand | 125.05 Thousand |
| Operating Income | - | - | - | - | -73.74 Thousand | -125.05 Thousand |
| Interest Expense | - | - | - | - | 82.75 Thousand | 121.79 Thousand |
| Income Tax Expense | - | - | - | - | -78.38 Thousand | -125.05 Thousand |
| Earnings before Tax | - | - | - | - | -336.95 Thousand | -246.85 Thousand |
| Net Income | - | - | - | - | -336.95 Thousand | -246.85 Thousand |
| Earnings Per Share Basic | - | - | - | - | -0.13 | -0.10 |
| Earnings Per Share Diluted | - | - | - | - | -0.13 | -0.10 |
| Weighted Average Shares Outstanding | - | - | - | - | 2.6 Million | 2.45 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | - | - | 2.6 Million | 2.45 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | - | - | - | -254.2 Thousand | -125.05 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2019 Q3 | 2019 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | 1152.00 | 296.00 |
| Gross Profit | - | - | - | - | -1152.00 | -296.00 |
| Operating Expenses | - | - | - | - | 19.64 Thousand | 21.65 Thousand |
| Selling, General and Administrative Expenses | - | - | - | - | 19.64 Thousand | 21.65 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | - | - | - | - | 20.79 Thousand | 21.94 Thousand |
| Operating Income | - | - | - | - | -20.79 Thousand | -21.94 Thousand |
| Interest Expense | - | - | - | - | - | 4645.00 |
| Income Tax Expense | - | - | - | - | - | 4645.00 |
| Earnings before Tax | - | - | - | - | -48.41 Thousand | -106.15 Thousand |
| Net Income | - | - | - | - | -48.41 Thousand | -106.15 Thousand |
| Earnings Per Share Basic | - | - | - | - | -0.01 | -0.04 |
| Earnings Per Share Diluted | - | - | - | - | -0.01 | -0.04 |
| Weighted Average Shares Outstanding | - | - | - | - | 4.76 Million | 2.67 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | - | - | 4.76 Million | 2.67 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | - | - | - | -19.64 Thousand | -21.65 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
CLRCR
ENTRA
1405
605089
253840
VEDANTASSET